Development of Bioanalytical Method And Validation For Quantification of Brivaracetam In Human Plasma By RP-HPLC

Registration ID: IJNRD_191697

Published ID: IJNRD2304370

DOI: Click Here to Get

Shubhangi B. Kanoje , Kanchan D. Nagrale , Rita D. Chakole , Manoj S. Charde

Bioanalytical method development, Protein precipitation extraction, Method Validation, Human Plasma, RP-HPLC

High-Performance Liquid Chromatography is an analytical method that has been developed and validated for the estimation of Brivaracetam in Human Plasma according to current regulatory guidelines for bioanalytical methods. Sample processing involved a simple protein precipitation extraction technique by acetonitrile as the extraction solvent. Methods: Separation is carried out on Sunfire-C18 plasma 5 µm (4.6 × 250 mm) column as a stationary phase, Mobile Phase: methanol + 0.1% OPA (orthophosphoric acid) in ratio (45: 55), at a flow rate of 0.7 ml/min. The sample was detected at a wavelength of 279 nm and the sample size was 20μl. The objective of method validation, according to ICH principles, is to show that an analytical technique is appropriate for the intended use. The standard calibration plot was found linear over a range of 10 to 50 µg/ml and the correlation coefficient was found to be (R2 =0.999). The % RSD value of intraday and interday precision is 0.17 and 0.04 respectively. The LOD and LOQ were found to be 0.115034 and 0.34587 for Brivaracetam. The developed method was eventually applied for quantification of the marketed formulation satisfactory result was obtained. Conclusions: It can be concluded that the developed bioanalytical method is capable of quantifying Brivaracetam from spiked human plasma samples. The method meets the requirements of the USFDA Guidelines and can be applied to Bioavailability/ Bioequivalence studies of Brivaracetam.

Published Paper   E-Certificate

Shubhangi B. Kanoje, Kanchan D. Nagrale, Rita D. Chakole, & Manoj S. Charde (April-2023). Development of Bioanalytical Method And Validation For Quantification of Brivaracetam In Human Plasma By RP-HPLC. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(4), d490-d499. https://ijnrd.org/papers/IJNRD2304370.pdf

Volume 8 Issue 4, April-2023

Pages : d490-d499

Paper Reg. ID: IJNRD_191697

Published Paper Id: IJNRD2304370

Downloads: 000121978

Research Area: Pharmacy

Country: Karad, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2304370.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2304370

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details